These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 32507912)

  • 1. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
    Gires O; Pan M; Schinke H; Canis M; Baeuerle PA
    Cancer Metastasis Rev; 2020 Sep; 39(3):969-987. PubMed ID: 32507912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
    Brown TC; Sankpal NV; Gillanders WE
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer.
    Sankpal NV; Fleming TP; Sharma PK; Wiedner HJ; Gillanders WE
    Oncogene; 2017 Jun; 36(26):3706-3717. PubMed ID: 28192403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
    Mohtar MA; Syafruddin SE; Nasir SN; Low TY
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
    Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
    Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
    Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
    Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells.
    Eslami-S Z; Cortés-Hernández LE; Alix-Panabières C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32764280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
    Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
    Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
    Gires O; Stoecklein NH
    Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
    Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
    J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
    Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
    Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of EpCAM in physiology and pathology of the epithelium.
    Martowicz A; Seeber A; Untergasser G
    Histol Histopathol; 2016 Apr; 31(4):349-55. PubMed ID: 26493939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.
    Herreros-Pomares A; Aguilar-Gallardo C; Calabuig-Fariñas S; Sirera R; Jantus-Lewintre E; Camps C
    Crit Rev Oncol Hematol; 2018 Jun; 126():52-63. PubMed ID: 29759567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
    Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D
    J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
    Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
    PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.